Advertisement
Canada markets closed
  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CAD/USD

    0.7264
    +0.0000 (+0.00%)
     
  • CRUDE OIL

    82.59
    -0.10 (-0.12%)
     
  • Bitcoin CAD

    84,767.73
    -3,167.97 (-3.60%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,381.70
    -6.70 (-0.28%)
     
  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     
  • 10-Yr Bond

    4.5850
    -0.0740 (-1.59%)
     
  • NASDAQ futures

    17,696.00
    +37.50 (+0.21%)
     
  • VOLATILITY

    18.21
    -0.19 (-1.03%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • NIKKEI 225

    37,896.32
    -65.48 (-0.17%)
     
  • CAD/EUR

    0.6806
    +0.0004 (+0.06%)
     

Does This Biotech Have the Secret to Conquering Covid Variants?

Does This Biotech Have the Secret to Conquering Covid Variants?

Gritstone Bio (NASDAQ: GRTS) is far from being the first to the coronavirus vaccine finish line. The biotech company's vaccine candidate just began phase 1 trials this year. Gritstone's clinical trials are in the earliest stage.